Molecular Sieves

Molecular sieves, 3A, powder

CAS: 308080-99-1 Molecular Formula: AlNaO6Si2 Molecular Weight (g/mol): 202.135 MDL Number: MFCD00131613 InChI Key: URGAHOPLAPQHLN-UHFFFAOYSA-N PubChem CID: 19758701 SMILES: [O-][Si](=O)[O-].[O-][Si](=O)[O-].[Na+].[Al+3]

Molecular sieves, 4A, powder

CAS: 70955-01-0 Molecular Formula: C20H25FN2O8 Molecular Weight (g/mol): 440.42 MDL Number: MFCD00131613 InChI Key: FJUZEZRZKVMAMD-UHFFFAOYNA-N PubChem CID: 73906282 IUPAC Name: (2R,3S)-2-[[(2R)-2-acetamido-3-(3-fluorophenyl)propanoyl]amino]-5-methoxy-4-methoxycarbonyl-3-methyl-5-oxopentanoic acid SMILES: COC(=O)C(C(C)C(NC(=O)C(CC1=CC(F)=CC=C1)NC(C)=O)C(O)=O)C(=O)OC

Medchemexpress LLC 4alpha-phorbol 12-myristate 13-acetate | 63597-44-4 | MFCD00153860 | 99.0% | 616.83 | C36H56O8 | 1 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

4alpha-phorbol 12-myristate 13-acetate is the inactive stereoisomer of TPA used as a negative control in experiments that monitor TPA-activated signaling events. It is supplied as a high-purity research reagent in a small-mass vial suitable for in vitro assays.

• Inactive negative control for TPA-activated events.
• High purity (99.0%) for reproducible results.
• Molecular formula C36H56O8 and molecular weight 616.83 for accurate identification.
• Supplied in a 1 mg package suitable for small-scale studies.

Cayman Chemical 15-hydroxy Prostaglandin Dehydrogenase Inhibitor Screening Kit, 384 Well

Cayman’s 15-PGDH Inhibitor Screening Assay Kit provides a robust and easy-to-use platform for identifying novel inhibitors of human 15-PGDH, the enzyme that catalyzes the oxidation of prostaglandins to 15-keto metabolites with reduced biological activity. Measurement of 15-PGDH activity is carried out by monitoring the reduction of NAD+ to NADH. The reduction of NAD+ to NADH is accompanied by an increase in fluorescence at 445 nm following excitation at 340 nm. The potent and reversible 15-PGDH inhibitor ML-148 Assay Reagent is included as a positive control and inhibits 15-PGDH with an IC50 value of 11 nM.

Cayman Chemical 15-hydroxy Prostaglandin Dehydrogenase Inhibitor Screening Kit, 96 Well

Cayman’s 15-PGDH Inhibitor Screening Assay Kit provides a robust and easy-to-use platform for identifying novel inhibitors of human 15-PGDH, the enzyme that catalyzes the oxidation of prostaglandins to 15-keto metabolites with reduced biological activity. Measurement of 15-PGDH activity is carried out by monitoring the reduction of NAD+ to NADH. The reduction of NAD+ to NADH is accompanied by an increase in fluorescence at 445 nm following excitation at 340 nm. The potent and reversible 15-PGDH inhibitor ML-148 Assay Reagent is included as a positive control and inhibits 15-PGDH with an IC50 value of 11 nM.

Cayman Chemical 15-hydroxy Prostaglandin Dehydrogenase Substrate Screening Kit, 96 Well

Cayman’s 15-hydroxy Prostaglandin Dehydrogenase (15-PGDH) Substrate Screening Assay Kit provides a robust and easy-to-use platform for identifying novel substrates of the metabolic enzyme 15-PGDH. Measurement of 15-PGDH activity is carried out by monitoring the rate of NAD+ reduction to NADH. The reduction of NAD+ to NADH is accompanied by an increase in fluorescence at 445 nm following excitation at 340 nm. Prostaglandin E2 (PGE2) is included as a positive control while 15-keto PGE2, an inactive metabolite of PGE2 formed by 15-PGDH, is included as a negative (background) control. This assay is also able to detect “slow” substrates, which are utilized by 15-PGDH less efficiently than PGE2.